Related Experiment Video
Updated: Jun 16, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Echinocandins as Biotechnological Tools for Treating Candida auris Infections
Elizabete de Souza Cândido1,2, Flávia Affonseca1, Marlon Henrique Cardoso1,2
1S-Inova Biotech, Programa de Pós Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande 79117900; Brazil.
Abstract:
Candida auris has been reported in the past few years as an invasive fungal pathogen of high interest. Its recent emergence in healthcare-associated infections triggered the efforts of researchers worldwide, seeking additional alternatives to the use of traditional antifungals such as azoles. Lipopeptides, specially the echinocandins, have been reported as an effective approach to control pathogenic fungi. However, despite its efficiency against C. auris, some isolates presented echinocandin resistance. Thus, therapies focused on echinocandins' synergism with other antifungal drugs were widely explored, representing a novel possibility for the treatment of C. auris infections.
More Related Videos
Related Concept Videos
Cryptococcal Meningitis
Inhibitors of Bacterial Protein Synthesis
Antifungal Agents

